Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 3/20 | 0.37 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.33 |
| ▸ | BDKRB1 | P46663 | 6/20 | 0.33 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6077854 | 1.00 | F10 (0.37) | F10KLKB1SLC1A2F2PRSS1 | |
| Acetic Acid SCHEMBL6078407 | 0.98 | F10 (0.36) | F10KLKB1SLC1A2F2PRSS1 | |
| SCHEMBL6077453 | 0.95 | F10 (0.36) | F10KLKB1SLC1A2F2PRSS1 | |
| SCHEMBL6077467 | 0.95 | F10 (0.36) | F10KLKB1SLC1A2F2PRSS1 | |
| SCHEMBL6079438 | 0.93 | F10 (0.38) | F10KLKB1F2PRSS1BDKRB1 | |
| SCHEMBL6079462 | 0.93 | F10 (0.38) | F10KLKB1F2PRSS1BDKRB1 | |
| Acetic Acid SCHEMBL6077426 | 0.93 | F10 (0.35) | F10KLKB1SLC1A2F2PRSS1 | |
| Acetic Acid SCHEMBL6077490 | 0.91 | F10 (0.37) | F10KLKB1F2PRSS1BDKRB1 | |
| SCHEMBL6078421 | 0.87 | F10 (0.36) | F10KLKB1SLC1A2LMNASMN1; SMN2 | |
| SCHEMBL6078437 | 0.87 | F10 (0.36) | F10KLKB1SLC1A2LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7056932-B2 | Heterocyclyl substituted 1-alkoxy acetic acid amides | HOFFMAN-LA ROCHE INC. (US) | 2006-06-06 | — | — | US | disclosed |
| US-20050137168-A1 | Heterocyclyl substituted 1-alkoxy acetic acid amides | HOFFMANN-LA ROCHE INC. | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137168-A1 | Heterocyclyl substituted 1-alkoxy acetic acid amides | F12, TFPI, F11 | F10 8/4885KLKB1 854/4885SLC1A2 2506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.